AR032524A1 - Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de - Google Patents

Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de

Info

Publication number
AR032524A1
AR032524A1 ARP020100329A ARP020100329A AR032524A1 AR 032524 A1 AR032524 A1 AR 032524A1 AR P020100329 A ARP020100329 A AR P020100329A AR P020100329 A ARP020100329 A AR P020100329A AR 032524 A1 AR032524 A1 AR 032524A1
Authority
AR
Argentina
Prior art keywords
molded
wrapped
pharmaceutical composition
capsules
amount
Prior art date
Application number
ARP020100329A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR032524A1 publication Critical patent/AR032524A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composiciones farmacéuticas para cápsulas moldeadas que comprenden Eudragit 4135F, presente en una cantidad de aproximadamente 50 a 90% p/p; un lubricante presente en una cantidad de 0 a aproximadamente 30% p/p; un excipiente modificador de la disolucion, presente en una cantidad aproximadamente 2,5 a aproximadamente 70% p/p y, opcionalmente un tensioactivo, presente en una cantidad de 0 a 10%, un plastificante presente en una cantidad de 0 a 10% p/p y/ o un agente de procesado, presente en una cantidad de 0 a aproximadamente 10% p/p. Dichas composiciones poliméricas farmacéuticamente aceptables son adecuadas para el moldeo por inyeccion de formas de dosificacion farmacéuticas unicas o de varios componentes que comprende una pluralidad de subunidades que contienen sustancia farmacologica y que son compartimientos de cápsulas y/ o subunidades solidas que comprenden una matriz solida de un polímero que contiene una sustancia farmacologica, estando conectadas las subunidades entre sí en la forma de dosificacion ensamblada por una soldadura entre las partes de la forma de dosificacion ensamblada.
ARP020100329A 2001-01-30 2002-01-30 Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de AR032524A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0102342.3A GB0102342D0 (en) 2001-01-30 2001-01-30 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
AR032524A1 true AR032524A1 (es) 2003-11-12

Family

ID=9907781

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP020100329A AR032524A1 (es) 2001-01-30 2002-01-30 Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de
ARP020100330A AR032525A1 (es) 2001-01-30 2002-01-30 Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP020100330A AR032525A1 (es) 2001-01-30 2002-01-30 Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de

Country Status (21)

Country Link
US (3) US20030049311A1 (es)
EP (5) EP2366382B1 (es)
JP (4) JP2004524300A (es)
KR (4) KR20120004558A (es)
CN (3) CN1529588B (es)
AR (2) AR032524A1 (es)
AU (3) AU2002242024B2 (es)
BR (2) BR0206627A (es)
CA (2) CA2437350A1 (es)
CZ (2) CZ20032003A3 (es)
ES (1) ES2399838T3 (es)
GB (1) GB0102342D0 (es)
HU (2) HUP0302857A3 (es)
IL (3) IL156716A0 (es)
MX (2) MXPA03006775A (es)
NO (2) NO20033143L (es)
NZ (2) NZ544259A (es)
PL (2) PL368554A1 (es)
TW (2) TWI257871B (es)
WO (2) WO2002060385A2 (es)
ZA (2) ZA200304810B (es)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227742B1 (en) 1996-10-18 2012-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
US7163693B1 (en) 1999-07-30 2007-01-16 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
MY142179A (en) 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
US8404716B2 (en) * 2002-10-15 2013-03-26 Celgene Corporation Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
US8404717B2 (en) * 2002-10-15 2013-03-26 Celgene Corporation Methods of treating myelodysplastic syndromes using lenalidomide
US11116782B2 (en) 2002-10-15 2021-09-14 Celgene Corporation Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
ATE461681T1 (de) * 2003-04-29 2010-04-15 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
NL1023720C2 (nl) * 2003-06-23 2004-12-28 Univ Eindhoven Tech Werkwijze voor het wijzigen van de transporteigenschappen van een materiaal, werkwijze voor het vrijmaken van een werkstof uit een implantaat, evenals implantaat met werkstof.
CA2533292C (en) * 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258949B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
EP1648418A4 (en) * 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2535177A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
CA2535780A1 (en) * 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
UY28500A1 (es) 2003-09-05 2005-04-29 Vertex Pharma Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
US8460710B2 (en) * 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
US7517581B2 (en) * 2003-09-26 2009-04-14 Parker-Hannifin Corporation Semipermeable hydrophilic membrane
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
JP2005187376A (ja) 2003-12-25 2005-07-14 Shin Etsu Chem Co Ltd 低置換度セルロースエーテル含有カプセル及びその製造方法
EP1702555B1 (en) * 2004-01-07 2016-12-07 Olympus Corporation Capsule type medical device, medical capsule enclosure and production method therefor
TW200539903A (en) * 2004-03-12 2005-12-16 Smithkline Beecham Plc Pharmaceutical formulations
WO2005113010A1 (ja) * 2004-05-24 2005-12-01 Qualicaps Co., Ltd. 表面改質および溶解性が改善された硬カプセル
CA2469339A1 (en) * 2004-06-07 2005-12-07 Bernard Charles Sherman Sustained release propafenone hydrochloride capsules
AU2005253957B2 (en) * 2004-06-08 2011-08-25 Janssen Pharmaceutica Nv Pharmaceutical compositions
CA2572292A1 (en) * 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060049154A1 (en) * 2004-09-09 2006-03-09 Clifford George M Jr System and method for bonding camera components after adjustment
WO2006055928A2 (en) 2004-11-19 2006-05-26 Smithkline Beecham Corporation Pharmaceutical product
CN101277950B (zh) * 2005-08-02 2013-03-27 弗特克斯药品有限公司 丝氨酸蛋白酶抑制剂
AR055395A1 (es) * 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
US7964624B1 (en) * 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
EP1954249B1 (en) 2005-11-18 2015-07-22 Glaxo Group Limited Machine and method for pharmaceutical and pharmaceutical-like product assembly
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
AU2005339699A1 (en) * 2005-12-30 2007-07-12 Accu-Break Technologies, Inc. Adhesively bonded dosage form
EP1991229A2 (en) 2006-02-27 2008-11-19 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
MX2008011868A (es) 2006-03-16 2008-12-15 Vertex Pharma Inhibidores deuterados de la proteasa de la hepatitis c.
EP2001498A4 (en) * 2006-03-20 2013-01-23 Vertex Pharma PHARMACEUTICAL COMPOSITIONS
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20080057086A1 (en) * 2006-09-01 2008-03-06 Pharmion Corporation Colon-targeted oral formulations of cytidine analogs
WO2008067829A1 (en) * 2006-12-05 2008-06-12 Universita' Degli Studi Di Parma New modules, new assemblage kits and new assemblies for the controlled release of substances
CA2679426A1 (en) * 2007-02-27 2008-09-04 Luc Farmer Inhibitors of serine proteases
EP2463285A1 (en) * 2007-02-27 2012-06-13 Vertex Pharmaceuticals Inc. Co-crystals and pharmaceutical compositions comprising the same
US20090162430A1 (en) * 2007-03-21 2009-06-25 Kariem Ezzat Mahmoud Gelatin Capsule With Extra Cap for Combined Therapies
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
WO2009029543A1 (en) 2007-08-24 2009-03-05 Aegis Therapeutics, Llc Controlled release formulations
MX2010002407A (es) * 2007-08-30 2010-03-26 Vertex Pharma Cocristales y composiciones farmaceuticas que los comprenden.
WO2009050192A1 (en) 2007-10-15 2009-04-23 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
US8293159B2 (en) * 2007-10-15 2012-10-23 Capsugel Belgium Method and apparatus for manufacturing filled linkers
EP2537506A1 (en) 2007-10-15 2012-12-26 Capsugel Belgium NV Linkers for multipart dosage forms for release of one or more parmaceutical compositions, and the resulting dosage forms
JP2011503048A (ja) * 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
MX363023B (es) 2008-05-15 2019-03-05 Celgene Corp Formulaciones orales de analogos de citidina y metodos para usar los mismos.
AU2009256572A1 (en) * 2008-06-13 2009-12-17 Capsugel Belgium Nv Hydroxypropyl cellulose capsule shell
WO2009154396A2 (en) * 2008-06-17 2009-12-23 Pharmapex Co., Ltd. Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
AR083150A1 (es) 2010-05-10 2013-02-06 Euro Celtique Sa Composiciones farmaceuticas que comprenden hidromorfona y naloxona
CA2798884C (en) 2010-05-10 2016-09-13 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
CN103601628B (zh) 2010-11-12 2015-11-18 深圳市有为化学技术有限公司 对位或间位官能团化芳香酮类化合物、其制备方法及其光聚合引发剂
EP2550863A1 (de) * 2011-07-27 2013-01-30 Bayer Intellectual Property GmbH Aktivstoffhaltige Partikel auf Polyacrylat-Basis
BR112014004753A2 (pt) * 2011-08-30 2017-03-28 Univ Gent formulação de liberação de multicamadas
BR112014003386A2 (pt) * 2011-10-12 2017-03-01 Dow Global Technologies Llc envoltório de uma forma de dosagem moldado por injeção, forma de dosagem e método para produzir um envoltório de uma forma de dosagem
BR112014014600A2 (pt) * 2011-12-16 2017-06-13 Combinent Biomedical Systems Inc dispositivos para administração vaginal de fármacos e métodos de fabricação
KR101378069B1 (ko) * 2012-05-17 2014-03-27 박정배 황칠나무 추출액을 이용한 막걸리 및 그의 제조방법
EP2911651B1 (en) * 2012-09-27 2016-06-22 Basf Se A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin e-derivative and at least one hydrophilic polymer
DE112014005175T5 (de) 2013-11-13 2016-07-21 Euro-Celtique S.A. Hydromorphon und Naloxon für die Behandlung von Schmerzen und Opioid-Darm-Dysfunktions-Syndrom
CN103937037B (zh) * 2014-04-28 2016-09-21 北京崇尚科技开发有限公司 用于制备空心胶囊的变性淀粉胶及其淀粉基质空心胶囊
AU2015284078B2 (en) 2014-07-03 2020-01-30 SpecGx LLC Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
ES2940302T3 (es) 2014-08-22 2023-05-05 Celgene Corp Métodos para tratar el mieloma múltiple con compuestos inmunomoduladores en combinación con anticuerpos
EP3452003A4 (en) * 2016-05-05 2019-06-26 Triastek, Inc. PHARMACEUTICAL FORM WITH CONTROLLED RELEASE
US10456975B2 (en) 2016-07-15 2019-10-29 Multiply Labs Inc. Multi-compartment capsule
CN106177971A (zh) * 2016-07-20 2016-12-07 贵州理工学院 含有薄荷醇的土豆淀粉胶囊壳
JP6742197B2 (ja) * 2016-08-29 2020-08-19 信越化学工業株式会社 ヒプロメロースフタル酸エステルの製造方法
EP3653203A4 (en) 2017-07-11 2020-06-24 Qualicaps Co., Ltd. ENTERAL HARD CAPSULE
EP3691615A1 (en) * 2017-10-02 2020-08-12 Novartis AG Method for producing a pharmaceutical carrier
EP3691617A1 (en) * 2017-10-02 2020-08-12 Novartis AG Pharmaceutical carrier design
US20210228491A1 (en) 2018-06-22 2021-07-29 Qualicaps Co., Ltd. Enteric hard capsule
EP3856160A4 (en) 2018-09-25 2022-07-06 SpecGx LLC ANTI-ABUSE IMMEDIATE RELEASE CAPSULES DOSAGE FORMS
EP3633215B1 (en) 2018-10-02 2021-07-07 Newfrey LLC Self-piercing rivet
WO2020212829A1 (en) * 2019-04-17 2020-10-22 Amruth Gowda Doddaveerappa Multi-component pharmaceutical single dosage forms and methods employed thereof
CN117500923A (zh) 2021-04-07 2024-02-02 巴特尔纪念研究院 用于鉴定和使用非病毒载体的快速设计、构建、测试和学习技术
WO2023145871A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法
WO2023145869A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 製剤用組成物の製造方法及び製剤の製造方法

Family Cites Families (196)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US110723A (en) * 1871-01-03 Improvement in car-replacers
US148514A (en) * 1874-03-10 Improvement in band-pulleys
US104501A (en) * 1870-06-21 Steam-radiator
US108492A (en) * 1870-10-18 Improvement in rufflers for sewing-machines
US148518A (en) * 1874-03-10 Improvement in mail-bag holders
US110721A (en) * 1871-01-03 Meat-cutters
US160042A (en) * 1875-02-23 Improvement in soles for boots and shoes
US87049A (en) * 1869-02-16 Improved cheese-cutter
US177496A (en) * 1876-05-16 gafney
US260814A (en) * 1882-07-11 Combined seeder and cultivator
NL156848B (nl) 1950-10-26 Philips Nv Inrichting voor het opwekken van tonen van een toonladder, alsmede muziekinstrument voorzien van een dergelijke inrichting.
US3186910A (en) 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
US3278521A (en) * 1963-02-08 1966-10-11 Hercules Inc Hydroxypropyl cellulose and process
US3394983A (en) 1963-06-14 1968-07-30 American Cyanamid Co Dip-dyeing capsules
FR1454013A (fr) 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3399803A (en) 1966-10-11 1968-09-03 Parke Davis & Co Self-locking medicament capsule
CA944689A (en) * 1970-07-28 1974-04-02 Claude Rene Capsules en matieres plastiques et leurs procedes de fabrication
US3779942A (en) * 1970-12-04 1973-12-18 Minnesota Mining & Mfg Capsules and process for forming capsules
US3723312A (en) * 1970-12-18 1973-03-27 Ppg Industries Inc Combined stain retardant and separator interleaving material for glass sheets
DE2428397C3 (de) 1974-06-12 1978-05-18 Scherer Hartkapsel Gmbh, 6930 Eberbach Zweiteilige Kapsel aus Hartgelatine
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
DE2722822C2 (de) * 1977-05-20 1984-11-08 Capsugel AG, Basel Verfahren zum Herstellen einer zum Aufnehmen eines viskosen Stoffes, insbesondere eines flüssigen Arzneimittels, geeigneten Steckkapsel
US4250097A (en) * 1978-03-08 1981-02-10 Syntex (U.S.A.) Inc. Compositions for and a method of preventing diabetic complications
FI63335B (fi) 1979-02-02 1983-02-28 Orion Yhtymae Oy Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne
US4281763A (en) * 1979-10-31 1981-08-04 Pace Joseph A Two-piece hardshell, soluble and digestible liquid containing gelatin capsule
US4498080A (en) * 1980-12-31 1985-02-05 Braintech, Inc. Apparatus and method for topographic display of multichannel data
US4766728A (en) * 1983-03-28 1988-08-30 Rexa Corporation Flow matching valve and hydraulic system employing same
USRE34390E (en) 1980-12-31 1993-09-28 Nicolet Instrument Corporation Apparatus and method for topographic display of multichannel EEG data
US4417591A (en) 1980-12-31 1983-11-29 Braintech, Inc. Apparatus and method for topographic display of multichannel EEG data
EP0091908A1 (en) 1981-10-21 1983-10-26 SMITH, Charles E A method and composition for substrate coating
JPS58134019A (ja) 1982-02-05 1983-08-10 Ono Pharmaceut Co Ltd プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
GR78492B (es) * 1982-03-26 1984-09-27 Warner Lambert Co
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
US4790881A (en) * 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4550238A (en) * 1982-11-05 1985-10-29 Warner-Lambert Company Apparatus and method for sealing capsules
USD285837S (en) * 1982-12-20 1986-09-23 Warner-Lambert Company Pharmaceutical capsule
US4487327A (en) 1982-12-21 1984-12-11 Grayson Robert E Locking capsule
US4557180A (en) 1983-03-28 1985-12-10 Rexa Corporation Control valve and hydraulic system employing same
US4696163A (en) 1983-03-28 1987-09-29 Rexa Corporation Control valve and hydraulic system employing same
US4625513A (en) 1983-03-28 1986-12-02 Rexa Corporation Controlled flow hydraulic system
US4543138A (en) 1983-07-07 1985-09-24 Eli Lilly & Company Capsule-sealing method and apparatus
US4564363A (en) 1983-07-13 1986-01-14 Smithkline Beckman Corporation Delayed action assembly
US4576284A (en) * 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738817A (en) 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US4673438A (en) 1984-02-13 1987-06-16 Warner-Lambert Company Polymer composition for injection molding
EP0164669B1 (de) 1984-06-13 1991-01-23 Röhm Gmbh Verfahren zum Überziehen von Arzneiformen
US4629621A (en) 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
US5082655A (en) 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
US4678516A (en) * 1984-10-09 1987-07-07 The Dow Chemical Company Sustained release dosage form based on highly plasticized cellulose ether gels
DE3438291A1 (de) 1984-10-19 1986-04-24 Röhm GmbH, 6100 Darmstadt Verfahren zur herstellung einer waessrigen ueberzugsmitteldispersion und ihre verwendung zum ueberziehen von arzneimitteln
GB2172569A (en) 1985-03-21 1986-09-24 Warner Lambert Co Improved capsule construction
EP0211079A4 (en) 1985-01-31 1988-02-15 Fujisawa Pharmaceutical Co BENDABLE CAPSULE WITH SEVERAL CHAMBERS, METHOD AND DEVICE FOR THEIR PRODUCTION.
DE3524963A1 (de) 1985-07-12 1987-01-22 Scherer R P Hartkapsel Gmbh Zweiteilige steckkapsel
ATE67401T1 (de) 1985-12-26 1991-10-15 Taisho Pharmaceutical Co Ltd Weiche nahtlose kapseln.
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4928840A (en) 1986-02-25 1990-05-29 American Home Products Corporation Tamper proof encapsulated medicaments
CH674800A5 (es) 1986-03-12 1990-07-31 Warner Lambert Co
DE3612212A1 (de) 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US4793493A (en) 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US4936461A (en) 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
DE3631826A1 (de) 1986-09-19 1988-03-31 Roehm Gmbh Herstellung eines methylmethacrylat-copolymerisats
US5074426A (en) * 1986-11-13 1991-12-24 Warner-Lambert Company Dividable capsule
JPH0787207B2 (ja) * 1986-11-13 1995-09-20 日本電信電話株式会社 集積回路試験装置
KR890003520Y1 (ko) 1986-12-20 1989-05-27 주식회사 서흥캅셀 의약용 캅셀
US4724019A (en) 1987-03-20 1988-02-09 Warner-Lambert Company Method and apparatus for sealing capsules
DE3720757A1 (de) 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5236689A (en) 1987-06-25 1993-08-17 Alza Corporation Multi-unit delivery system
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
DE3735260A1 (de) 1987-10-17 1989-04-27 Bosch Gmbh Robert Verschliessvorrichtung fuer zweiteilige kapseln
ATE82680T1 (de) * 1988-05-04 1992-12-15 Smith Kline French Lab Kautablette.
DE3830013C2 (de) 1988-09-03 1996-10-17 Bosch Gmbh Robert Füll- und Schließmaschine für zweiteilige Kapseln
US4944906A (en) 1988-10-11 1990-07-31 Spirex Corporation Methods of injection molding and extruding wet hygroscopic ionomers
US5135752A (en) 1988-10-14 1992-08-04 Zetachron, Inc. Buccal dosage form
US5244668A (en) * 1988-10-14 1993-09-14 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5004601A (en) 1988-10-14 1991-04-02 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US5139790A (en) 1988-10-14 1992-08-18 Zetachron, Inc. Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith
US4936074A (en) 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US5728088A (en) * 1988-12-13 1998-03-17 Alza Corporation Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
DE3902653A1 (de) 1989-01-30 1990-08-02 Roehm Gmbh Elastomere acrylharze
US6200600B1 (en) 1989-02-16 2001-03-13 Btg International Limited Controlled delay release device
DE3907019A1 (de) 1989-03-04 1990-09-06 Roehm Gmbh Thermoplastisch verarbeitbare loesungsmittelbestaendige kunststoffmischungen
WO1990012567A1 (en) 1989-04-21 1990-11-01 Moskovsky Avtomobilestroitelny Institut (Vtuz-Zil) Device for controlled dosing of active substances into an operative medium
JPH0729926B2 (ja) * 1989-07-25 1995-04-05 大塚製薬株式会社 易吸収性製剤用組成物
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5456919A (en) 1989-12-29 1995-10-10 Bristol-Myers Squibb Company Capsule and caplet combination
DE4002904A1 (de) 1990-02-01 1991-08-08 Roehm Gmbh Verfahren zum imidieren eines methacrylester-polymerisats
CA2098992A1 (en) 1991-01-30 1992-07-31 Patrick S. L. Wong Osmotic device for delayed delivery of agent
US5976571A (en) 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5674530A (en) 1991-01-31 1997-10-07 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
CA2068402C (en) 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
DE4121652A1 (de) 1991-06-29 1993-01-07 Roehm Gmbh Schlagzaeh-modifizierungsmittel
US5225202A (en) 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
DE4138513A1 (de) 1991-11-23 1993-05-27 Basf Ag Feste pharmazeutische retardform
JP2512258B2 (ja) * 1992-03-11 1996-07-03 松下電器産業株式会社 シ―ト給送装置
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
US5312008A (en) * 1993-05-26 1994-05-17 Davis Bradford L Personal time capsule
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE4402666A1 (de) 1994-01-29 1995-08-03 Roehm Gmbh Verfahren zum kurzzeitigen Behandeln einer Kunststoffschmelze mit einem flüssigen Behandlungsmittel und dabei hergestellter thermoplastischer Kunststoff
DE4413350A1 (de) 1994-04-18 1995-10-19 Basf Ag Retard-Matrixpellets und Verfahren zu ihrer Herstellung
ATE226090T1 (de) * 1994-04-22 2002-11-15 Yamanouchi Pharma Co Ltd Kolon-spezifisches arzneistofffreisetzungssystem
DE19509807A1 (de) 1995-03-21 1996-09-26 Basf Ag Verfahren zur Herstellung von Wirkstoffzubereitungen in Form einer festen Lösung des Wirkstoffs in einer Polymermatrix sowie mit diesem Verfahren hergestellte Wirkstoffzubereitungen
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
DE9414065U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
US5593696A (en) 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
US6245350B1 (en) * 1994-12-16 2001-06-12 Warner-Lambert Company Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
DE4445498A1 (de) 1994-12-20 1996-06-27 Roehm Gmbh Universell verträgliche Pigmentdispergatoren
ATE216576T1 (de) * 1995-02-08 2002-05-15 Yamanouchi Europ Bv Vehrfahren zur herstellung von beta-lactam antibiotikum enthaltenden oralen dosisformen
DE19504832A1 (de) 1995-02-14 1996-08-22 Basf Ag Feste Wirkstoff-Zubereitungen
DE19504831A1 (de) 1995-02-14 1996-09-05 Basf Ag Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose
DE29502547U1 (de) * 1995-02-16 1995-03-30 Röhm GmbH, 64293 Darmstadt Thermoplastisches Überzugs- und Bindemittel für Arzneiformen
DE19509805A1 (de) 1995-03-21 1996-09-26 Basf Ag Transparente, schnell freisetzende Zubereitungen von nichtsteroidalen Analgetica
SG80553A1 (en) * 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
DE19531277A1 (de) 1995-08-25 1997-02-27 Basf Ag Verwendung von Lipiden als Hilfsmittel bei der Herstellung von festen Arzneiformen nach dem Schmelzextrusionsverfahren
US5769267A (en) 1995-11-09 1998-06-23 Warner-Lambert Company Container
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
DE19544562B4 (de) 1995-11-30 2004-05-27 Röhm GmbH & Co. KG Verfahren zur Herstellung von Poly(meth)acrylimiden mit bei thermischer Belastung verbesserter Farbstabilität und daraus erhältliche Formkörper
FR2747042B1 (fr) * 1996-04-05 1998-06-05 Besins Iscovesco Lab Medicament a base de progesterone et d'oestradiol
CA2277017C (en) * 1997-01-06 2002-11-26 Pfizer Inc. Rapidly releasing and taste-masking pharmaceutical dosage form
DE19701441C2 (de) 1997-01-17 1998-11-05 Roehm Gmbh Verfahren zur Herstellung farbneutraler Polymethylmethacrylat-Formmassen
DE19718597C1 (de) 1997-05-02 1999-01-07 Roehm Gmbh Zweistufiges Verfahren zur Entwässerung von Kunststoffdispersionen
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
DE19721467A1 (de) 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
DE19733505A1 (de) 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
DE19753299A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753297A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753298A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19753300A1 (de) 1997-12-01 1999-06-02 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19800927A1 (de) 1998-01-13 1999-07-15 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
GB9801363D0 (en) * 1998-01-22 1998-03-18 Danbiosyst Uk Novel dosage form
US5931776A (en) * 1998-03-09 1999-08-03 Dotolo Research Corporation Speculum having dissolvable tip
DE19812688A1 (de) 1998-03-23 1999-09-30 Basf Ag Verfahren zur Herstellung von festen Dosierungsformen
DE19821788C1 (de) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermales Therapeutisches System (TTS) Pergolid enthaltend
DE19918435A1 (de) * 1998-07-23 2000-01-27 Roehm Gmbh Überzugs- und Bindemittel für orale oder dermale Arzneiformen
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
WO2000016742A1 (en) * 1998-09-24 2000-03-30 The Procter & Gamble Company Chewable compositions containing dextromethorphan
DE19843904A1 (de) 1998-09-24 2000-03-30 Basf Ag Feste Dosierungsform mit polymerem Bindemittel
US6139875A (en) * 1998-09-29 2000-10-31 Eastman Chemical Company Aqueous enteric coating composition and low gastric permeability enteric coating
CA2361496C (en) * 1999-02-04 2011-06-07 Abbott Laboratories Ph independent extended release pharmaceutical formulation
IT1316684B1 (it) * 1999-03-13 2003-04-24 Bosch Gmbh Robert Supporto delle parti di capsule in una macchina di caricamento e dichiusura per capsule in due parti
US6248807B1 (en) * 1999-03-15 2001-06-19 Fina Technology, Inc. Method for the preparation of core-shell morphologies from polybutadiene-polystyrene graft copolymers
DE19914605A1 (de) 1999-03-30 2000-10-05 Roehm Gmbh Polyalkylmethacrylat-Plastisole mit verbesserten Fließeigenschaften
US6340476B1 (en) * 1999-04-06 2002-01-22 Armaquest, Inc. Pharmaceutical dosage form for pulsatile delivery of methylphenidate
US7163693B1 (en) * 1999-07-30 2007-01-16 Smithkline Beecham Plc Multi-component pharmaceutical dosage form
GB2358382B (en) * 1999-11-17 2003-01-29 Reckitt Benckiser Rigid water-soluble containers
DE19958007A1 (de) * 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
DE19960494A1 (de) 1999-12-15 2001-06-21 Knoll Ag Vorrichtung und Verfahren zum Herstellen von festen wirkstoffhaltigen Formen
DE19961334A1 (de) * 1999-12-17 2001-06-21 Roehm Gmbh Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
JP4840793B2 (ja) 2000-03-23 2011-12-21 塩野義製薬株式会社 撥水性成分を配合することを特徴とする難水溶性薬物の腸溶顆粒製剤
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
DE10043868A1 (de) 2000-09-04 2002-04-04 Roehm Gmbh PMMA Formmassen mit verbesserter Schlagzähigkeit
DE10054051A1 (de) 2000-10-31 2002-05-29 Roehm Gmbh PMMA-Formmasse mit verbesserter Kälteschlagzähigkeit
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
US6949154B2 (en) 2001-07-28 2005-09-27 Boehringer Ingelheim Pharma Kg Method and apparatus for sealing medicinal capsules
US7217381B2 (en) 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
JP2003171277A (ja) 2001-12-07 2003-06-17 Wyeth Lederle Japan Ltd 薬物放出時間制御型固形製剤
AU2003202879A1 (en) * 2002-01-04 2003-07-24 Ivax Research, Inc. Drug delivery system for sustained delivery of glipizide
USD481456S1 (en) * 2002-01-30 2003-10-28 Smithkline Beecham P.L.C. Capsule
DE10204890A1 (de) 2002-02-06 2003-08-14 Roehm Gmbh Schlagzähe Formmasse und Formkörper
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
US20030194428A1 (en) 2002-04-10 2003-10-16 Miller Frederick H. Process for encapsulating multi-phase, multi-compartment capsules
MY142179A (en) * 2002-07-25 2010-10-15 Glaxo Group Ltd Multicomponent pharmaceutical dosage form
DE10243062A1 (de) 2002-09-16 2004-03-25 Röhm GmbH & Co. KG Heißwasserwechseltestbeständiges Sanitärmaterial aus PMMA-Formmasse oder schlagzäher PMMA-Formmasse
DE10260089A1 (de) 2002-12-19 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von wässrigen Dispersionen
DE10260065A1 (de) 2002-12-19 2004-07-01 Röhm GmbH & Co. KG Kern-Schale-Teilchen zur Schlagzähmodifizierung von Poly(meth)acrylat-Formmassen
DE10329938A1 (de) 2003-07-02 2005-03-17 Röhm GmbH & Co. KG Kunststoffkörper mit mikrostrukturierter Oberfläche
DE10349144A1 (de) 2003-10-17 2005-05-12 Roehm Gmbh Polymermischung für mattierte Spritzgußteile
DE10349142A1 (de) 2003-10-17 2005-05-12 Roehm Gmbh Polymermischung sowie deren Verwendung für Spritzgußteile
DE10351535A1 (de) 2003-11-03 2005-06-09 Röhm GmbH & Co. KG Mehrschichtfolie aus (Meth)acrylatcopolymer und Polycarbonat
DE10354379A1 (de) 2003-11-20 2005-06-23 Röhm GmbH & Co. KG Formmasse, enthaltend ein Mattierungsmittel
US20050142203A1 (en) * 2003-12-30 2005-06-30 Grant Heinicke Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same
WO2005070401A1 (en) 2004-01-16 2005-08-04 Glaxo Group Limited Encapsulation of lipid-based formulations in enteric polymers
DE102004022540A1 (de) 2004-05-05 2005-12-08 Röhm GmbH & Co. KG Formmasse für Formkörper mit hoher Witterungsbeständigkeit
JP4354360B2 (ja) * 2004-07-26 2009-10-28 Ｏｋｉセミコンダクタ株式会社 降圧電源装置
DE102004045296A1 (de) 2004-09-16 2006-03-23 Röhm GmbH & Co. KG Verwendung von Polyalkyl (meth) acrylat-Perlpolymerisaten und Formmasse zur Herstellung von extrudierten Formteilen mit mattierter Oberfläche
US9713592B2 (en) 2005-04-06 2017-07-25 Mallinckrodt Llc Matrix-based pulse release pharmaceutical formulation
US20080014257A1 (en) * 2006-07-14 2008-01-17 Par Pharmaceutical, Inc. Oral dosage forms
WO2009050192A1 (en) * 2007-10-15 2009-04-23 Glaxo Group Limited Paneled capsule shells for release of pharmaceutical compositions
US8293159B2 (en) * 2007-10-15 2012-10-23 Capsugel Belgium Method and apparatus for manufacturing filled linkers
US20090148514A1 (en) * 2007-10-15 2009-06-11 Matthews Wayne M Multipart capsule for staged release of one or more pharmaceutical compositions
EP2537506A1 (en) * 2007-10-15 2012-12-26 Capsugel Belgium NV Linkers for multipart dosage forms for release of one or more parmaceutical compositions, and the resulting dosage forms
JP2011503048A (ja) * 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤

Also Published As

Publication number Publication date
WO2002060385A2 (en) 2002-08-08
PL368547A1 (en) 2005-04-04
EP1389093A4 (en) 2009-03-11
MXPA03006775A (es) 2003-10-24
JP2009173668A (ja) 2009-08-06
PL208634B1 (pl) 2011-05-31
JP2004524300A (ja) 2004-08-12
EP2366383A3 (en) 2012-02-22
KR20030072611A (ko) 2003-09-15
KR101128228B1 (ko) 2012-03-26
CA2437350A1 (en) 2002-08-08
US20030049311A1 (en) 2003-03-13
GB0102342D0 (en) 2001-03-14
HUP0302857A3 (en) 2005-05-30
WO2002060384A3 (en) 2003-05-30
IL156716A0 (en) 2004-01-04
BR0206627A (pt) 2004-02-25
BR0206752A (pt) 2004-02-10
NZ544259A (en) 2008-01-31
EP2366382B1 (en) 2015-05-13
CN102198114A (zh) 2011-09-28
TWI322015B (en) 2010-03-21
KR20120004558A (ko) 2012-01-12
NO20033143D0 (no) 2003-07-09
AU2005248931A1 (en) 2006-01-19
WO2002060384A2 (en) 2002-08-08
WO2002060385A3 (en) 2003-11-27
US20110300212A1 (en) 2011-12-08
CN1489456A (zh) 2004-04-14
EP2366383A2 (en) 2011-09-21
ZA200305045B (en) 2004-04-28
PL368554A1 (en) 2005-04-04
CZ20032003A3 (en) 2004-04-14
CN1529588A (zh) 2004-09-15
CZ20031980A3 (en) 2004-03-17
CN1529588B (zh) 2011-08-10
CN1489456B (zh) 2011-02-23
JP2004522746A (ja) 2004-07-29
AU2009212847A1 (en) 2009-09-24
EP2366384B1 (en) 2013-04-03
NO20033143L (no) 2003-09-19
ZA200304810B (en) 2004-04-23
KR20100006587A (ko) 2010-01-19
CA2436416A1 (en) 2002-08-08
NO20033384L (no) 2003-09-25
US8367101B2 (en) 2013-02-05
EP1363607B1 (en) 2012-11-21
AU2009212847B2 (en) 2012-04-26
EP1389093A2 (en) 2004-02-18
HUP0302876A2 (hu) 2003-12-29
ES2399838T3 (es) 2013-04-03
EP2366384A3 (en) 2012-02-22
AR032525A1 (es) 2003-11-12
EP2366384A2 (en) 2011-09-21
AU2002242024B2 (en) 2006-01-12
HUP0302857A2 (hu) 2003-12-29
MXPA03006884A (es) 2003-11-13
KR20030072610A (ko) 2003-09-15
NZ544503A (en) 2008-05-30
IL156783A0 (en) 2004-05-12
HUP0302876A3 (en) 2005-05-30
EP1363607A4 (en) 2009-03-11
US20030068369A1 (en) 2003-04-10
TWI257871B (en) 2006-07-11
NO20033384D0 (no) 2003-07-29
EP1363607A2 (en) 2003-11-26
EP2366382A3 (en) 2012-02-15
EP2366382A2 (en) 2011-09-21
CA2436416C (en) 2012-07-17
IL156716A (en) 2009-07-20
JP2012229224A (ja) 2012-11-22

Similar Documents

Publication Publication Date Title
AR032524A1 (es) Composicion farmaceutica para capsulas moldeadas; composicion farmaceutica para envueltas de capsulas moldeadas; envuelta, elemento de union o separador de capsula moldeados por inyeccion con las mismas; forma de dosificacion farmaceutica de varios componentes y conjunto de formas de dosificacion de
AR048033A1 (es) Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion
AR065970A2 (es) Una composicion farmaceutica oral solida que comprende una combinacion de metformin y glibenclamida y uso de dicha composicion
AR024966A1 (es) Formulacion farmaceutica
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ECSP066553A (es) Formas de administración masticables, no comprimidas dosificadas individualmente.
UY29890A1 (es) Composiciones farmacéuticas sólidas que contienen pregabalina
NO20060852L (no) Farmasoytiske preparater
ES2117015T3 (es) Composiciones que contienen sumatriptan.
CR7921A (es) Formulaciones farmaceuticas liquidas de palonosetron
AR010634A1 (es) Composicion farmaceutica en forma de una solucion para la administracion de inhibidores de proteasa hiv
UY26306A1 (es) Composición para la dosificación oral, de disolución instantanea
ES2091649T3 (es) Uso de rifaximina y composiciones farmaceuticas que la contienen en el tratamiento de la dispepsia gastrica causada por helicobacter pylori.
UY26529A1 (es) Composición de gliburida.
AR076305A1 (es) Composiciones de capsulas biodisponibles de compuesto alfa-(n-sulfonamido) acetamida amorfo
AR037592A1 (es) Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno
MX9308188A (es) Glucomanano de konjac facilmente disponible, como un excipiente de liberacion sostenida.
ES2206081T1 (es) Procedimiento para preparar composiciones farmaceuticas para uso con formulaciones de gelatina blanda.
AR033688A1 (es) Composicion parenteral reconstituible
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
GT200200078A (es) Metodo para fabricar una composicion farmaceutica de dosis baja que tiene una distribucion y potencia del farmaco uniformes.
ES2057225T3 (es) Una composicion para la preparacion de una vitamina d3 activa en forma de dosificacion y su procedimiento de preparacion.
BRPI0510694A (pt) composições farmacêuticas compreendendo ingredientes ativos concentrados encapsuladas em gelatina mole
PE20080313A1 (es) Formulaciones de liberacion pulsada de fenilefrina y composiciones farmaceuticas
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax

Legal Events

Date Code Title Description
FB Suspension of granting procedure